Santa Maria, California-based Landec said it will rename itself as Lifecore Biomedical “in the near future” and change its Nasdaq ticker to LFCR.
Landec named Jim Hall as its new CEO effective yesterday. Hall served as president of Chaska, Minnesota-based Lifecor since 2017. Landec CFO John Morberg will remain with the company.
Lifecore manufactures sodium hyaluronate for medical applications and offers contract development and manufacturing organization services for injectable pharmaceuticals and medica…